ARTIFICIAL INTELLIGENCE AND CRACKING THE CODE TO CANCER

摘要

IN ANTICIPATION OF THE 50TH ANNI- versary of NASA astronauts landing on the moon, Newsweek is spotlighting pioneers in science and technology, highlighting their very own moonshots and how they hope to change the world. Abraham Heifets is the CEO and cofounder of Atomwise, a biotech company using patented deep learning artificial intelligence technology to predict and discover which drugs will be better, safer and more potent for cancer patients.